Welcome and introduction - Highlights from the latest ODYSSEY OUTCOMES data

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in to view the resources

About the speaker

Professor Andreas Michael Zeiher

Institute of Cardiovascular Regeneration, Frankfurt (Germany)

6 More presentations in this session

Presentation thumbnail

Learnings from the latest PCSK9i results and profiles of patients who may benefit the most: post- ACS patients with elevated atherogenic lipid levels

Professor P. Steg (Paris, FR)

Presentation thumbnail

Learnings from the latest PCSK9i results and and profiles of patients who may benefit the most: efficacy and safety of alirocumab in ODYSSEY OUTCOMES patients with diabetes

Professor K. Ray (London, GB)

Presentation thumbnail

Learnings from the latest PCSK9i results and profiles of patients who may benefit the most: a comprehensive review of the latest lipid lowering therapies outcomes data

Professor C. Cannon (Boston, US)

Presentation thumbnail

Clinical implications for post-ACS patients

Doctor S. Goodman (Toronto, CA)

Presentation thumbnail

Roundtable: learnings in practice

Professor P. Steg (Paris, FR) Professor A. Zeiher (Frankfurt, DE)

Access the full session

Session thumbnail

Identifying patients who may benefit most from PCSK9i: highlights from the latest ODYSSEY OUTCOMES data

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

A patient with NSTEMI - what matters from a patient's point of view

Congress Session

Cardiology Toolbox: how to take a history - tips, tricks, and hard data from the experts

Congress Presentation

Case 1 - AF-CARE and atrial fibrillation treatment considerations: the UK perspective

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources